Articles & Video
A clinical trial investigator's insider view
Site consultant Kate O’Brien speaks to two clinical trial investigators and a research nurse about the challenges facing sites today.
3 case studies for implementing wearables in clinical trials
We look at three case studies of how wearables are being used in clinical trials and try to separate reality from hype.
10 predictions for clinical trials in 2020 - INDUSTRY VOICES
We asked 10 clinical trial insiders their predictions for how clinical trials will most change in 2020.
How can the success of clinical partnerships be measured? - INDUSTRY VOICES
We asked five industry experts which metrics can be measured to judge the success of clinical partnerships.
How close are we to fully virtual oncology clinical trials?
What steps still need to be taken to implement virtual clinical trials in oncology?
How clinical trial Principal Investigators can maintain oversight
How can Principal Investigators maintain clinical trial oversight and delegate staff roles? Site consultant Kate O’Brien offers some advice.
The single technology that will have the biggest impact on clinical trials - INDUSTRY VOICES
We ask seven clinical trials experts which single technology they think will have the biggest impact on clinical trials.
How far can we trust AI in clinical trials?- INDUSTRY VOICES
Seven industry experts tell us what they see as the greatest challenges in using AI in clinical trials and how they can best be solved.
Virtual trials and Real World Evidence: The global shift in clinical operations
We deep-dive into our State of the Industry Report 2019 to understand how companies are utilizing virtual trials and Real World Evidence in their clinical trial operations.
The operational challenges facing virtual clinical trials - INDUSTRY VOICES
Virtual clinical trials face a number of operational challenges before they can be fully and effectively implemented. We ask five industry insiders about how to overcome them.
Outsourcing in clinical trials: an EU struggle? - Data report analysis
In a recent report, we investigated what today’s clinical trials professionals see as the biggest risks faced in managing relationships with third-party organisations.
Using adaptive design and biomarkers in early phase clinical trials - INDUSTRY VOICES
Clinical trial experts gave us their view on the current potential for using adaptive design and biomarkers in early phase clinical trials.
Transforming protocol deviation and management with TransCelerate
How the TransCelerate Protocol Deviations Initiative is helping guide sites and sponsors on the ICH E3 guideline.
Technology central to 63% of companies' patient engagement strategy
Wearables and AI in clinical trials: We delve into survey data around how respondents are integrating technology into their clinical trials and the challenges they are facing.
Clinical trial site finances: Tips for budgets, payments and invoicing
Clinical trial site finances, payments and budgeting can often be frustrating. Site consultant Kate O’Brien looks at the issues and solutions.
Is AI really understood in the clinical trials industry? - Data report analysis
The latest State of the Industry 2019 survey revealed fascinating insights into what opportunities and obstacles organisations currently see in working with AI in clinical trials.
How eConsent and TransCelerate's ‘Clinical Trial Registry of the Future’ can improve patient engagement
Discover how TransCelerate is championing eConsent in clinical trials and developed an idea for the "Clinical Trial Registry of the Future".
Emerging conventions in early clinical development - data report analysis
While exploring how organisations are currently innovating early clinical development, our latest State of the Industry survey revealed interesting insights.
Making the patient's life as easy as possible
Site consultant Kate O’Brien looks at how the lives of patients in clinical trials can be made easier in clinical trials to improve retention.